Bryan E Roberts - Net Worth and Insider Trading

Bryan E Roberts Net Worth

The estimated net worth of Bryan E Roberts is at least $345 Million dollars as of 2024-05-13. Bryan E Roberts is the Director, 10% Owner of ZELTIQ Aesthetics Inc and owns about 5,458,233 shares of ZELTIQ Aesthetics Inc (ZLTQ) stock worth over $308 Million. Bryan E Roberts is the Director of 10x Genomics Inc and owns about 1,287,825 shares of 10x Genomics Inc (TXG) stock worth over $33 Million. Bryan E Roberts is also the Director, 10% Owner of Castlight Health Inc and owns about 1,269,230 shares of Castlight Health Inc (CSLT) stock worth over $3 Million. Besides these, Bryan E Roberts also holds Ironwood Pharmaceuticals Inc (IRWD) . Details can be seen in Bryan E Roberts's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bryan E Roberts has not made any transactions after 2020-05-20 and currently still holds the listed stock(s).

Transaction Summary of Bryan E Roberts

Bryan E Roberts Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bryan E Roberts owns 11 companies in total, including 10x Genomics Inc (TXG) , Castlight Health Inc (CSLT) , and Achaogen Inc (AKAOQ) among others .

Click here to see the complete history of Bryan E Roberts’s form 4 insider trades.

Insider Ownership Summary of Bryan E Roberts

Ticker	Comapny	Transaction Date	Type of Owner
TXG	10x Genomics Inc	2020-09-16	director
CSLT	Castlight Health Inc	2021-06-10	director & 10 percent owner
AKAOQ	Achaogen Inc	2018-06-05	director
		2016-05-26	director
		2015-11-02	director
		2015-03-10	director & 10 percent owner
		2014-07-30	10 percent owner
		2013-11-15	10 percent owner
		2009-12-22	10 percent owner
		2009-05-07	director
		2007-05-30	director

Bryan E Roberts Latest Holdings Summary

Bryan E Roberts currently owns a total of 4 stocks. Among these stocks, Bryan E Roberts owns 5,458,233 shares of ZELTIQ Aesthetics Inc (ZLTQ) as of November 14, 2013, with a value of $308 Million and a weighting of 89.39%. Bryan E Roberts owns 1,287,825 shares of 10x Genomics Inc (TXG) as of May 20, 2020, with a value of $33 Million and a weighting of 9.71%. Bryan E Roberts also owns 1,269,230 shares of Castlight Health Inc (CSLT) as of November 18, 2015, with a value of $3 Million and a weighting of 0.75%. The other 1 stocks Ironwood Pharmaceuticals Inc (IRWD) have a combined weighting of 0.15% among all his current holdings.

Latest Holdings of Bryan E Roberts

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ZLTQ	ZELTIQ Aesthetics Inc	2013-11-14	5,458,233	56.48	308,281,000
TXG	10x Genomics Inc	2020-05-20	1,287,825	25.99	33,470,572
CSLT	Castlight Health Inc	2015-11-18	1,269,230	2.05	2,601,922
IRWD	Ironwood Pharmaceuticals Inc	2015-03-10	73,995	7.00	517,965

Holding Weightings of Bryan E Roberts

Bryan E Roberts Form 4 Trading Tracker

According to the SEC Form 4 filings, Bryan E Roberts has made a total of 0 transactions in ZELTIQ Aesthetics Inc (ZLTQ) over the past 5 years. The most-recent trade in ZELTIQ Aesthetics Inc is the sale of 575,000 shares on November 14, 2013, which brought Bryan E Roberts around $7 Million.

According to the SEC Form 4 filings, Bryan E Roberts has made a total of 3 transactions in 10x Genomics Inc (TXG) over the past 5 years, including 2 buys and 1 sells. The most-recent trade in 10x Genomics Inc is the sale of 3,100,000 shares on May 20, 2020, which brought Bryan E Roberts around $242 Million.

According to the SEC Form 4 filings, Bryan E Roberts has made a total of 0 transactions in Castlight Health Inc (CSLT) over the past 5 years. The most-recent trade in Castlight Health Inc is the acquisition of 121,300 shares on November 18, 2015, which cost Bryan E Roberts around $467,005.

More details on Bryan E Roberts's insider transactions can be found in the Insider Trading History of Bryan E Roberts table.

Insider Trading History of Bryan E Roberts

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bryan E Roberts Trading Performance

GuruFocus tracks the stock performance after each of Bryan E Roberts's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bryan E Roberts is -2.97%. GuruFocus also compares Bryan E Roberts's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bryan E Roberts within 3 months outperforms 5 times out of 8 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Bryan E Roberts's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Bryan E Roberts

Average Return

Average return per transaction

Outperforming Transactions

8 out of 8 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	3.51
Relative Return to S&P 500(%)	3.17

Bryan E Roberts Ownership Network

Ownership Network List of Bryan E Roberts

No Data

Ownership Network Relation of Bryan E Roberts

Bryan E Roberts Owned Company Details

What does 10x Genomics Inc do?

Who are the key executives at 10x Genomics Inc?

Bryan E Roberts is the director of 10x Genomics Inc. Other key executives at 10x Genomics Inc include director & 10 percent owner & Chief Executive Officer Serge Saxonov , director & See Remarks Benjamin J. Hindson , and Chief Financial Officer Justin J. Mcanear .

10x Genomics Inc (TXG) Insider Trades Summary

Over the past 18 months, Bryan E Roberts made no insider transaction in 10x Genomics Inc (TXG). Other recent insider transactions involving 10x Genomics Inc (TXG) include a net sale of 90,937 shares made by Serge Saxonov , a net sale of 36,912 shares made by Benjamin J. Hindson , and a net sale of 9,758 shares made by Justin J. Mcanear .

In summary, during the past 3 months, insiders sold 11,959 shares of 10x Genomics Inc (TXG) in total and bought 0 shares, with a net sale of 11,959 shares. During the past 18 months, 208,804 shares of 10x Genomics Inc (TXG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 208,804 shares.

10x Genomics Inc (TXG)'s detailed insider trading history can be found in Insider Trading Tracker table.

10x Genomics Inc Insider Transactions

No Available Data

What does Castlight Health Inc do?

Who are the key executives at Castlight Health Inc?

Bryan E Roberts is the director & 10 percent owner of Castlight Health Inc. Other key executives at Castlight Health Inc include 10 percent owner Venrock Management Vi, Llc , 10 percent owner Venrock Associates Vi, L.p. , and 10 percent owner Venrock Partners Management Vi, Llc .

Castlight Health Inc (CSLT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Castlight Health Inc (CSLT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Castlight Health Inc (CSLT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Castlight Health Inc (CSLT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Castlight Health Inc Insider Transactions

No Available Data

What does Achaogen Inc do?

Who are the key executives at Achaogen Inc?

Bryan E Roberts is the director of Achaogen Inc. Other key executives at Achaogen Inc include 10 percent owner Robert W Duggan , Chief Operating Officer Elizabeth Bhatt , and See Remarks Gary Loeb .

Achaogen Inc (AKAOQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Achaogen Inc (AKAOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achaogen Inc (AKAOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Achaogen Inc (AKAOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Achaogen Inc Insider Transactions

No Available Data

What does Vitae Pharmaceuticals Inc do?

Who are the key executives at Vitae Pharmaceuticals Inc?

Bryan E Roberts is the director of Vitae Pharmaceuticals Inc. Other key executives at Vitae Pharmaceuticals Inc include Chief Financial Officer Richard Steven Morris , General Counsel Scott Applebaum , and Chief Medical Officer Carole Sable .

Vitae Pharmaceuticals Inc (VTAE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Vitae Pharmaceuticals Inc (VTAE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vitae Pharmaceuticals Inc (VTAE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Vitae Pharmaceuticals Inc (VTAE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vitae Pharmaceuticals Inc Insider Transactions

No Available Data

What does ZELTIQ Aesthetics Inc do?

Who are the key executives at ZELTIQ Aesthetics Inc?

Bryan E Roberts is the director of ZELTIQ Aesthetics Inc. Other key executives at ZELTIQ Aesthetics Inc include director & 10 percent owner Andrew N Schiff , SVP & Research and Development Bradley Hauser , and SVP of Global Marketing Danika R Harrison .

ZELTIQ Aesthetics Inc (ZLTQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ZELTIQ Aesthetics Inc (ZLTQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ZELTIQ Aesthetics Inc (ZLTQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ZELTIQ Aesthetics Inc (ZLTQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

ZELTIQ Aesthetics Inc Insider Transactions

No Available Data

What does Ironwood Pharmaceuticals Inc do?

Who are the key executives at Ironwood Pharmaceuticals Inc?

Bryan E Roberts is the director & 10 percent owner of Ironwood Pharmaceuticals Inc. Other key executives at Ironwood Pharmaceuticals Inc include SVP & Chief Financial Officer Sravan Kumar Emany , Chief Commercial Officer Thomas A Mccourt , and SVP & Chief Business Officer Andrew Davis .

Ironwood Pharmaceuticals Inc (IRWD) Insider Trades Summary

Over the past 18 months, Bryan E Roberts made no insider transaction in Ironwood Pharmaceuticals Inc (IRWD). Other recent insider transactions involving Ironwood Pharmaceuticals Inc (IRWD) include a net sale of 479,266 shares made by Thomas A Mccourt , a net sale of 26,346 shares made by Andrew Davis , and a net sale of 16,544 shares made by Ronald Silver .

In summary, during the past 3 months, insiders sold 0 shares of Ironwood Pharmaceuticals Inc (IRWD) in total and bought 17,604 shares, with a net purchase of 17,604 shares. During the past 18 months, 729,221 shares of Ironwood Pharmaceuticals Inc (IRWD) were sold and 53,676 shares were bought by its insiders, resulting in a net sale of 675,545 shares.

Ironwood Pharmaceuticals Inc (IRWD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ironwood Pharmaceuticals Inc Insider Transactions

No Available Data

What does Adverum Biotechnologies Inc do?

Who are the key executives at Adverum Biotechnologies Inc?

Bryan E Roberts is the 10 percent owner of Adverum Biotechnologies Inc. Other key executives at Adverum Biotechnologies Inc include Chief Development Officer Setareh Seyedkazemi , Chief Financial Officer Linda M Rubinstein , and Chief Scientific Officer Brigit Riley .

Adverum Biotechnologies Inc (ADVM) Insider Trades Summary

Over the past 18 months, Bryan E Roberts made no insider transaction in Adverum Biotechnologies Inc (ADVM). Other recent insider transactions involving Adverum Biotechnologies Inc (ADVM) include a net purchase of 130,000 shares made by Lupher, Jr. Mark L. , a net purchase of 100,000 shares made by Linda M Rubinstein , and a net purchase of 100,000 shares made by James Paul Scopa .

In summary, during the past 3 months, insiders sold 0 shares of Adverum Biotechnologies Inc (ADVM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,810 shares of Adverum Biotechnologies Inc (ADVM) were sold and 33,000 shares were bought by its insiders, resulting in a net purchase of 26,190 shares.

Adverum Biotechnologies Inc (ADVM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Adverum Biotechnologies Inc Insider Transactions

No Available Data

What does Anacor Pharmaceuticals Inc do?

Who are the key executives at Anacor Pharmaceuticals Inc?

Bryan E Roberts is the 10 percent owner of Anacor Pharmaceuticals Inc. Other key executives at Anacor Pharmaceuticals Inc include Executive VP and CFO Graeme Bell , EVP and General Counsel Ryan T Sullivan , and director & President and CEO Paul L Berns .

Anacor Pharmaceuticals Inc (ANAC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Anacor Pharmaceuticals Inc (ANAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anacor Pharmaceuticals Inc (ANAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Anacor Pharmaceuticals Inc (ANAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Anacor Pharmaceuticals Inc Insider Transactions

No Available Data

What does Neurocrine Biosciences Inc do?

Who are the key executives at Neurocrine Biosciences Inc?

Bryan E Roberts is the 10 percent owner of Neurocrine Biosciences Inc. Other key executives at Neurocrine Biosciences Inc include Chief Regulatory Officer Ingrid Delaet , Chief Commerical Officer Eric Benevich , and Chief Scientific Officer Jude Onyia .

Neurocrine Biosciences Inc (NBIX) Insider Trades Summary

Over the past 18 months, Bryan E Roberts made no insider transaction in Neurocrine Biosciences Inc (NBIX). Other recent insider transactions involving Neurocrine Biosciences Inc (NBIX) include a net sale of 247,240 shares made by Eric Benevich , a net sale of 150,252 shares made by Eiry Roberts , and a net sale of 61,528 shares made by Julie Cooke .

In summary, during the past 3 months, insiders sold 275,180 shares of Neurocrine Biosciences Inc (NBIX) in total and bought 0 shares, with a net sale of 275,180 shares. During the past 18 months, 1,153,642 shares of Neurocrine Biosciences Inc (NBIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,153,642 shares.

Neurocrine Biosciences Inc (NBIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Neurocrine Biosciences Inc Insider Transactions

No Available Data

What does athenahealth Inc do?

Who are the key executives at athenahealth Inc?

Bryan E Roberts is the director of athenahealth Inc. Other key executives at athenahealth Inc include Chief Financial Officer Marc A Levine , director & other: Executive Chairman Jeffrey R Immelt , and EVP and CFAO Kristi Ann Matus .

athenahealth Inc (ATHN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of athenahealth Inc (ATHN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of athenahealth Inc (ATHN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

athenahealth Inc (ATHN)'s detailed insider trading history can be found in Insider Trading Tracker table.

athenahealth Inc Insider Transactions

No Available Data

What does XenoPort Inc do?

Who are the key executives at XenoPort Inc?

Bryan E Roberts is the director of XenoPort Inc. Other key executives at XenoPort Inc include See Remarks William G Harris , 10 percent owner & other: Possible Member of 10% Group Deerfield Management Company, L.p. (series C) , and 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. .

XenoPort Inc (XNPT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of XenoPort Inc (XNPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XenoPort Inc (XNPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

XenoPort Inc (XNPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

XenoPort Inc Insider Transactions

No Available Data

Bryan E Roberts Mailing Address

Above is the net worth, insider trading, and ownership report for Bryan E Roberts. You might contact Bryan E Roberts via mailing address: C/o Venrock Associates, 2494 Sand Hill Road Ste 200, Menlo Park Ca 94025.

Discussions on Bryan E Roberts

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.